Tilray just posted the most confusing great quarter in cannabis. Revenue hit a record $257.1M, up 23%, while the cannabis business itself shrank 13% to $56.1M and the company burned $27.4M in free cash flow. The diversification strategy worked on the top line and failed on the cash line, which tells you everything about where this industry is.
Did the diversification strategy actually work?
On revenue, yes, and it is not close. A cannabis company that grows 23% while its cannabis sales shrink by double digits has proven the hedge works as a top line story. Beverages are now 39% of revenue, bigger than cannabis itself. International cannabis grew 21% to $16.2M with EMEA up 71%, which shows the cannabis business outside the US still has legs even as the domestic market grinds.
But revenue is the easy part. Gross profit rose 35% to $77.5M and margin expanded from 27% to 30%, so the mix shift is not just bigger, it is healthier. The strategy did what it was designed to do.
What does the cash burn tell us?
This is where the celebration stops. Operating cash outflow hit $16.5M against $1.3M a year ago, free cash flow was negative $27.4M, and the net loss was $40M. Adjusted EBITDA of $9.2M looks fine until you notice the cash walking out the door.
The read is simple: diversification bought revenue, not self sufficiency. A company burning nearly $30M in a quarter still needs either its cannabis business to recover or its beverage brands to start carrying the whole load on cash, not just sales. Record revenue with deepening cash burn is a bridge, and bridges need to land somewhere.
What is the lesson for operators?
Do not confuse a bigger company with a safer one. Tilray proved you can outgrow a shrinking core market by buying into adjacent categories, which is genuinely impressive execution. But the cash flow says the model is still in transition, and transitions end in one of two places: the new businesses fund the company, or the company keeps raising money to fund the transition.
For smaller operators the takeaway is narrower. You cannot BrewDog your way out of a bad market. What you can do is what Tilray got right underneath the deals: protect margin while you grow, because 30% gross margin is what keeps a 23% growth story alive long enough to finish the job.
That tension between scale and survival is the same one in Hoodie’s LA County data, where MSOs grew per store while local operators slipped. Big operators play a different game, as I wrote when cannabis MSOs started backing an anti cannabis Senate candidate. More of this analysis lives in the cannabis business collection.
Frequently Asked Questions
- What did Tilray report for the quarter? Record revenue of $257.1M, up 23% year over year, with gross profit of $77.5M, up 35%, and margin expanding to 30%.
- How far has cannabis fallen as a share of the business? Cannabis revenue fell 13% to $56.1M, now 22% of total revenue versus 31% a year ago.
- What drove the record? Beverages at $101.5M, up 82% on the BrewDog acquisition, and pharma distribution at $84.3M, up 14%. International cannabis grew 21%.
- How bad is the cash burn? Operating cash outflow was $16.5M versus $1.3M a year earlier, free cash flow was negative $27.4M, and the net loss was $40M.
- What should operators take away? Diversification can fix the top line, but only margin and cash flow fix the business. Grow the mix without losing the discipline.